NASDAQ:SVA

Sinovac Reports Unaudited First Half of 2018 Financial Results

BEIJING, Nov. 8, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products inChina, announced today its unaudited financial results for the six months endedJune 30, 2018. Financial highlights * Sales revenue for the...

2018-11-08 20:00 510

U.S. District Court in Massachusetts Denies 1Globe's Motion for Preliminary Injunction to Enjoin Sinovac's Issuance of Shares

BEIJING, Oct. 17, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:  SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products inChina, today announced that the United States District Court of the District ofMassachusetts denied 1Globe Capital LLC's ("1Globe") August 20...

2018-10-17 19:00 1109

DOJ Closes Investigation of Sinovac

BEIJING, Sept. 17, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products inChina, today announced that the U.S. Department of Justice ("DOJ") has closed its investigation, with no charges, into possible violations of...

2018-09-17 19:00 943

SEC Concludes Investigation of Sinovac

BEIJING, Aug. 20, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products inChina, today announced that the U.S. Securities and Exchange Commission ("SEC") has concluded its investigation into possible violations of th...

2018-08-20 19:00 1164

Sinovac Raises $86.73 Million Through Private Placement Transaction

* Vivo Capital and Advantech Capital Each Hold an Approximately 8.3% Stake in Sinovac After the Private Placement Transaction * Proceeds Will Be Used to Fund Improvement and Construction of Facilities for R&D Relating to Quality Control and Production of New Vaccines Projects * Sinovac's Boa...

2018-07-03 20:30 1083

Sinovac Files Motion for Summary Judgment on Rights Agreement in Delaware Chancery Court

* The summary judgment motion asks the Delaware Court to ascertain whether a trigger event under its Rights Agreement has occurred * The Company recently obtained information demonstrating that the Sinobioway Consortium and the Dissident Shareholdersreached an agreement in advance of the Annu...

2018-06-26 21:25 1955

Sinovac Biotech Relaunches Company Website

BEIJING, June 11, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA ) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the company has relaunched its website, at ww...

2018-06-11 21:00 484

Sinovac Files 2017 Annual Report on Form 20-F and Reports Unaudited Second Half, Audited Full Year 2017 Financial Results

BEIJING, May 11, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products inChina, announced today that it has filed its annual report for the year ended December 31 on Form 20-F (the "2017 Annual Report") with the U.S....

2018-05-11 21:10 2056

Sinovac Forced to Temporarily Suspend Hepatitis A Vaccine Production Line Due to Disruptive Actions taken by Minority Shareholder of Sinovac Beijing

Actions of Aihua Pan continue to harm the Company's shareholders and customers BEIJING, May 8, 2018 /PRNewswire/ --  Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac " or the "Company"), a leading provider of biopharmaceutical products inChina, today announced it has been forced to suspend production...

2018-05-08 21:29 897

Sinovac Forced to Temporarily Suspend Flu Vaccine Production Due to Disruptive Actions taken by Minority Shareholder of Sinovac Beijing

BEIJING, May 1, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac " or the "Company"), a leading provider of biopharmaceutical products inChina, today announced it has been forced to temporarily suspend its flu vaccine production and destroy the flu vaccines it is currently produc...

2018-05-01 19:00 867

Sinovac Forced to Plan to Destroy Bacterial Seeds intended for Pneumo Vaccine Production and Postpone Site Inspection

BEIJING, April 30, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products inChina, today announced it has been forced to destroy the bacterial seeds intended for use in the production of its 23-valent pneumococcal pol...

2018-04-30 21:25 998

Sinovac Temporarily Blocks Access to Its Websites

BEIJING, April 30, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products inChina, today announced that Aihua Pan, the Chairman of the Board of the Company's controlled Chinese subsidiary, Sinovac Biotech Co., Ltd. ("...

2018-04-30 21:00 771

Sinovac to Delay Filing of 2017 Annual Report on Form 20-F Following Actions Taken by the Minority Shareholder of Sinovac Beijing

BEIJING, April 27, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products inChina, today announced that it will delay the filing of its annual report on Form 20-F forthe year 2017 (the "2017 Annual Report"). The delay...

2018-04-27 20:30 1652

Sinovac Enters into Amendment to Amalgamation Agreement for Going-Private Transaction

BEIJING, April 27, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that on April 26, 2018, it entered into Amendment No. 2 to the Amalgamation Agreement (the "Amendment") to further ame...

2018-04-27 19:31 1595

Sinovac Announces Preliminary Results of Phase III Trial on sIPV

BEIJING, April 19, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac " or the "Company"), a leading provider of biopharmaceutical products inChina, today announced preliminary results of a phase III clinical study on Sabin inactivated polio vaccine ("sIPV") developed by Sinovac Bi...

2018-04-19 21:10 328

Sinovac Sets the Record Straight Regarding False Statements by Shandong Sinobioway Biomedicine Co., Ltd.

- Expresses Concern over Aggressive and Damaging Actions Taken by a Minority Shareholder of Sinovac's Beijing Subsidiary – - Reaffirms Commitment to Take All Appropriate Actions to Protect Company and Shareholder Interests – BEIJING, April 18, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: S...

2018-04-19 04:30 320

Sinovac Enters into Amendment to Amalgamation Agreement for Going-Private Transaction

BEIJING, March 27, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that on March 26, 2018, it entered into Amendment No. 1 to the Amalgamation Agreement (the "Amendment") to amend the A...

2018-03-27 19:40 312

Sinovac Sets the Record Straight Regarding False Statements by Unauthorized Third Parties

BEIJING, March 15, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today responded to public statements made by other parties falsely claiming to control the Company, including a press release false...

2018-03-15 18:24 313

Sinovac Amends Shareholder Rights Plan

BEIJING, March 6, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has amended its shareholder rights plan.  The amendment extends the expiration date of the ...

2018-03-07 05:01 279

Sinovac Announces Enhancement of Corporate Governance and Management of China Operating Entity

BEIJING, March 5, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products inChina, announced today actions taken to enhance the corporate governance and management of Sinovac Biotech Co., Ltd. ("Sinovac Beijing"), the ...

2018-03-06 09:44 371
12